Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes

Business Wire•24/09/2026•08:00 ET

* Fully automated, multiplex autoantibody detection solution, enabling population-wide screening programs

Get started

Create a free account to read the full story and Whiz Insights.

Already have an account? Log in